- Ownership
- Activity
PBAX Stock Ownership Activity
PHOENIX BIOTECH ACQUISI-CL A 13F holders
No value investing guru has made any change to the PHOENIX BIOTECH ACQUISI-CL A (PBAX) position according to the gurus' latest SEC quarterly report(s).
Which gurus or hedge funds are buying PBAX now?
According to the latest SEC filing(s) PHOENIX BIOTECH ACQUISI-CL A (PBAX) has not been purchased by any super investor.
To see more about who is investing in PHOENIX BIOTECH ACQUISI-CL A (PBAX), please go to the PBAX ownership page.
2022 Q1
(1 result)
Current price: $5.85
40.97%
Reported price*: $9.91
2021 Q4
(1 result)
Current price: $5.85
40.97%
Reported price*: $9.91
2 of 2
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.
Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.